DENTSPLY SIRONA (NASDAQ:XRAY) Releases Quarterly Earnings Results, Meets Estimates

DENTSPLY SIRONA (NASDAQ:XRAY) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $0.42 earnings per share for the quarter, meeting the consensus estimate of $0.42, RTT News reports. The company had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. DENTSPLY SIRONA’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.39 EPS. DENTSPLY SIRONA updated its FY24 guidance to $2.00-$2.10 EPS.

DENTSPLY SIRONA Trading Down 3.8 %

Shares of DENTSPLY SIRONA stock traded down $1.16 during trading on Thursday, hitting $29.02. The company’s stock had a trading volume of 1,870,996 shares, compared to its average volume of 3,270,496. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. DENTSPLY SIRONA has a 52 week low of $26.27 and a 52 week high of $43.24. The stock has a market cap of $6.02 billion, a price-to-earnings ratio of -48.68, a price-to-earnings-growth ratio of 1.21 and a beta of 1.00. The stock has a 50-day moving average price of $32.34 and a two-hundred day moving average price of $32.76.

DENTSPLY SIRONA Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date was Wednesday, March 27th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s payout ratio is presently -103.22%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Barrington Research restated an “outperform” rating and issued a $41.00 price objective on shares of DENTSPLY SIRONA in a report on Thursday, April 18th. SVB Leerink assumed coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They issued an “outperform” rating and a $42.00 price objective for the company. Piper Sandler raised their price objective on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a report on Friday, January 12th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of “Moderate Buy” and an average target price of $39.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.